Literature DB >> 18843132

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

Iain Stephenson, Karl G Nicholson, Katja Hoschler, Maria C Zambon, Kathy Hancock, Joshua DeVos, Jacqueline M Katz, Michaela Praus, Angelika Banzhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18843132     DOI： 10.1056/NEJMc0805274

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

1.  MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Authors:  Surender Khurana; Nitin Verma; Jonathan W Yewdell; Anne Katrin Hilbert; Flora Castellino; Maria Lattanzi; Giuseppe Del Giudice; Rino Rappuoli; Hana Golding
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Industry meeting demands for more effective vaccines.

Authors:  John Carroll
Journal:  Biotechnol Healthc       Date:  2009-08

Review 3.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

4.  Vaccinate before the next pandemic?

Authors:  Klaus Stöhr
Journal:  Nature       Date:  2010-05-13       Impact factor: 49.962

5.  Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

Authors:  Grazia Galli; Kathy Hancock; Katja Hoschler; Joshua DeVos; Michaela Praus; Monia Bardelli; Carmine Malzone; Flora Castellino; Chiara Gentile; Teresa McNally; Giuseppe Del Giudice; Angelika Banzhoff; Volker Brauer; Emanuele Montomoli; Maria Zambon; Jacqueline Katz; Karl Nicholson; Iain Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

Review 6.  H5N1 vaccines in humans.

Authors:  Mariana Baz; Catherine J Luke; Xing Cheng; Hong Jin; Kanta Subbarao
Journal:  Virus Res       Date:  2013-05-28       Impact factor: 3.303

7.  Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

Review 8.  Current prospects and future challenges for nasal vaccine delivery.

Authors:  Helmy Yusuf; Vicky Kett
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

9.  Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.

Authors:  Leo L M Poon; Y H Connie Leung; John M Nicholls; Pin-Yu Perera; Jack H Lichy; Masafumi Yamamoto; Thomas A Waldmann; J S Malik Peiris; Liyanage P Perera
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines.

Authors:  George Milne; Joel Kelso; Heath Kelly
Journal:  J R Soc Interface       Date:  2009-09-15       Impact factor: 4.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.